Biblio
“Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
, “Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1065-82, 2016.
, “Sporadic Cases with Novel Mutations and Pedigree in Hereditary Leukoencephalopathy with Axonal Spheroids.”, J Alzheimers Dis, vol. 56, no. 3, pp. 893-898, 2017.
, “Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
, “Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1067-1078, 2017.
, “Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.”, J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
, “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
, “Excretion of Amyloid-β in the Gastrointestinal Tract and Regulation by the Gut Microbiota.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1153-1162, 2022.
, “Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.”, J Alzheimers Dis, vol. 91, no. 2, pp. 637-651, 2022.
, “tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.”, J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
, “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
, “Microglia-Astrocyte Communication in Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 3, pp. 785-803, 2023.
, “Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 691-701, 2017.
, “Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”, J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
, “Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 509-520, 2017.
, “Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?”, J Alzheimers Dis, vol. 63, no. 1, pp. 217-225, 2018.
, “Distinct Patterns of Cognitive Aging Modified by Education Level and Gender among Adults with Limited or No Formal Education: A Normative Study of the Mini-Mental State Examination.”, J Alzheimers Dis, vol. 49, no. 4, pp. 961-9, 2016.
, “Glucagon-Like Peptide-2 Receptor is Involved in Spatial Cognitive Dysfunction in Rats After Chronic Cerebral Hypoperfusion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1559-1576, 2018.
, “DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 263-274, 2017.
, “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.
, “Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex.”, J Alzheimers Dis, vol. 62, no. 1, pp. 85-92, 2018.
, “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
,